|
Volumn 62, Issue 3, 2005, Pages 942-
|
Treatment of thymoma and prognostic factors: In regard to Zhu et al. (Int J Radiat Oncol Biol Phys 2004;60:1113-1119) [3]
a b c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
IMATINIB;
STEM CELL FACTOR;
CANCER INVASION;
CANCER STAGING;
DISEASE SEVERITY;
HISTOLOGY;
HUMAN;
LETTER;
METASTASIS;
PRIORITY JOURNAL;
PROGNOSIS;
STAINING;
THYMOMA;
THYMUS CANCER;
WORLD HEALTH ORGANIZATION;
HUMANS;
NEOPLASM PROTEINS;
NEOPLASM STAGING;
PROTO-ONCOGENE PROTEINS C-KIT;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RETROSPECTIVE STUDIES;
THYMOMA;
THYMUS NEOPLASMS;
|
EID: 20344378192
PISSN: 03603016
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijrobp.2005.03.011 Document Type: Letter |
Times cited : (1)
|
References (6)
|